Skip to main content
SpringerLink
Log in

Chinese biotech: the need for innovation and higher standards

  • Careers and Recruitment
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Can Hong Kong serve as the bridge for the development of biotech in mainland China?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sino-US Drug Development Forum, organized by the Chinese Biopharmaceutical Association USA (Washington, DC, November 9, 2005). http://www.cba-usa.org/html/SUDDF_102105.pdf

Download references

Author information

Authors and Affiliations

  1. ActoKine Therapeutics and president of Student Vision,

    Grace H W Wong

Authors
  1. Grace H W Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, G. Chinese biotech: the need for innovation and higher standards. Nat Biotechnol 24, 221–222 (2006). https://doi.org/10.1038/nbt0206-221

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0206-221

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation